Glaukos (GKOS) News
NYSE: GKOSHealth CareMedical/Dental InstrumentsUSD
165.69+4.40 (+2.73%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
GKOS news summary
We found 9 recent headlines mentioning Glaukos (GKOS): 7 in the past week and 7 in the past 30 days, most often from Nasdaq, Investing.com, Seeking Alpha. For price context, GKOS is up 2.73% at $165.69. The most recent story, "Glaukos Reports Positive Phase 4 Results For IDose TR With Cataract Surgery", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Glaukos headlines
- Glaukos Reports Positive Phase 4 Results For IDose TR With Cataract Surgery(RTTNews) - Friday, Glaukos Corporation (GKOS) announced positive topline results from a Phase 4 study evaluating iDose TR in combination with cataract surgery in patients with open-angle glaucoma…Nasdaq
- Why is Glaukos stock sliding today?Investing.com
- Glaukos slips as insider selling overshadows positive trial data for eye therapySeeking Alpha
- Eli Lilly, Glaukos among market cap stock movers on ThursdayInvesting.com
- Glaukos' Epioxa Shows Durable Three-Year Results In Keratoconus(RTTNews) - Glaukos Corp. (GKOS) on Wednesday reported three-year results from a Phase 3 extension study evaluating Epioxa, its epithelium-on corneal cross-linking therapy for keratoconus.Nasdaq
- Glaukos options flow shows bearish hedge as GKOS rallies 6.6%Investing.com
- Can ISRG's Single-Port Platform Become the Next Billion-Dollar Franchise?Intuitive Surgical SP platform is gaining momentum as procedures, utilization and placements rise, with expanding indications and global adoption fueling growth.NasdaqISRG, EW, GKOS
- Idexx (IDXX) Down 7.8% Since Last Earnings Report: Can It Rebound?Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.NasdaqIDXX, GKOS
- Why Is ISRG Investing More Aggressively in R&D Despite Macro Headwinds?Intuitive Surgical is boosting R&D despite macro headwinds, targeting AI, robotics and new procedures to expand its market and drive long-term growth.NasdaqISRG, EW, GKOS